Stock Taper
SCREENER COMPARE ANY 2 STOCKS
EMBC
EMBECTA CORP.
NASDAQ
$5.05
▲ UP 1.61% (0.08)

KEY STATISTICS

Market Cap$299.60 M
52w High$15.55
52w Low$2.77
Dividend Yield7.24%
FrequencyQuarterly
P/E1.94
Volume1.47M
Shares Out.59.33M

COMPANY

LEADERSHIP

Devdatt Kurdikar
CHIEF EXECUTIVE
Devdatt Kurdikar

COMPENSATION 2026

Salary$976,923
Stock Awards$7,000,008
Incentive Plan Pay$1,399,540
All Other Comp.$23,617
Total$9,400,088

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 22, 2022
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,850

PRICE TARGET

Target High$5.00
Target Low$5.00
Target Median$5.00
Target Consensus$5.00

UPCOMING EARNINGS

DateNov 24, 2026
DayTuesday
Rev. Est.$269.71M
NOV
24
TUE

PRICE

$5.05 ▲ UP 1.61% (+$0.08)
$5.00$5.05$5.10$5.159:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM5.05

About Embecta Corp.

https://www.embecta.com ↗

Embecta Corp. is a medical device company founded in 1924, based in Parsippany, NJ, offering diabetes management products like pen needles, syringes, safety devices, and digital tools to wholesalers and distributors worldwide.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT EMBECTA CORP. IS KNOWN FOR

Nano™ 2nd Gen Pen Needles
Nano™ 2nd Gen Pen Needles

A line of pen needles designed for comfortable and effective insulin delivery for people with diabetes. This product is central to Embecta's core business and a key focus of their current marketing and brand transition efforts.

COMPETITORS

COMPETITOR
BDX COMPARE
MDT COMPARE
NVO COMPARE
PODD COMPARE
TNDM COMPARE

Revenue by Products

IconPRODUCTQ4-2025Q1-2026Q2-2026Q3-2026
Safety$68.8M $37.3M ▼$34.3M ▼$36.7M ▲
Product and Service Other$7.5M $3.6M ▼$4M ▲$15.6M ▲
Manufacturing Facility$10M $4.1M ▼$2.5M ▼$5.3M ▲

Revenue by Geography

MapREGIONFY2022FY2023FY2024FY2025
UNITED STATES$600.3M $601.4M ▲$607.2M ▲$579.1M ▼
NonUS$529.2M $519.4M ▼$515.9M ▼$501.3M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
119
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.00% · 1.8M
XSU.TO
0.01% · 1.6M
FNDA
0.02% · 408.8K
DES
0.08% · 336.2K
ISMD
0.31% · 211.9K
PSC
0.02% · 118.0K
GSSC
0.05% · 107.5K
SLY
0.18% · 106.1K
PRFZ
0.01% · 82.9K
SQLV
0.72% · 59.1K
XRSG.L
0.01% · 48.3K
AGNG
0.16% · 30.1K
XHYH
0.29% · 29.0K
FHLC
0.00% · 26.4K
ROSC
0.20% · 22.0K
WSCSRI.SW
0.01% · 17.3K
DFUS
0.00% · 12.1K
VETS
0.29% · 10.8K
IVSS
0.15% · 8.5K
EBIT
0.27% · 6.4K
AFSM
0.01% · 3.9K
PINK
0.00% · 3.1K
URTY
0.00% · 2.4K
KBFR
0.11% · 2.4K
HEJD
0.06% · 2.4K
RESM
0.01% · 156

INSTITUTIONAL OWNERSHIP

SHARES OWNED
84.81%
HOLDERS
511
TOP 12 OF 511 · RANKED BY POSITION SIZE
Blackrock Inc.
9.2M sh · $114.93M
Blackrock, Inc.
9.2M sh · $81.04M
Vanguard Group Inc
5.5M sh · $77.1M
American Century Companies Inc
5.2M sh · $73.18M
Yacktman Asset Management LP
4.3M sh · $14.07M
River Road Asset Management, LLC
3.4M sh · $30.49M
Deerfield Management Company, L.P. (Series C)
2.8M sh · $32.69M
State Street Corp
2.5M sh · $22.51M
Jefferies Financial Group Inc.
2.4M sh · $20.82M
Ameriprise Financial Inc
2.0M sh · $6.65M
Morgan Stanley
2.0M sh · $6.51M
Sio Capital Management, LLC
1.8M sh · $16.33M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets4
Debt To Equity1
Price To Earnings3
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Tom Cole
Tom Cole
Purchase
2022-04-01
SENATE TRADES
Jacklyn Rosen
Jacklyn Rosen
Exchange
2022-04-01

INSIDER TRADES

★
OFFICER: SVP AND CFO
Elguicze Jacob
Purchase · 20.0K shares
2026-08-12
★
OFFICER: PRES, PHARM SVC&PROD MGMT, CLO
Mann Jeffrey Z
Purchase · 20.0K shares
2026-08-12
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Kurdikar Devdatt
Purchase · 30.0K shares
2026-08-12
★
DIRECTOR
HOMBACH ROBERT J.
Purchase · 45.0K shares
2026-08-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 2
UNDERPERFORM 1
3 GRADES IN THE LAST 12 MONTHS
B of A Securities UNDERPERFORM BTIG NEUTRAL Mizuho NEUTRAL

SECTORS PEERS

PEERPRICE
CDNA$49.79COMPARE
VIR$10.83COMPARE
PSNL$17.07COMPARE
MRVI$7.68COMPARE
PRME$3.61COMPARE
AQST$5.02COMPARE
EVH$4.60COMPARE
EBS$5.91COMPARE